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Purpose: Moxifloxacin is a third-generation synthetic fluoroquinolone anti-
bacterial agent. It’s antibacterial spectrum includes enteric Gram-(+) rods,
Gram-() rods, atypical bacteria, and anaerobic bacteria. This drug utiliza-
tion evaluation (DUE) study could help to improve increasing efficacy of
pharmacotherapy. Switch of injection Moxifloxacin to oral form will save
medical expense.
Methods: This study is a retrospective cases reviewed study which assessed
Moxifloxacin injection form converted to oral dosage form of Moxifloxacin.
Data collected from 01/04/2014 to 30/06/2014 inpatients using Moxifloxacin
in a regional hospital in Taichung, Taiwan. Inpatients using Moxifloxacin
routinely were included in the study. There were 110 cases recruiting in
this study. Assessment of the cases met the reasonable criteria included in-
dications, doses, frequency of administrations, and seven-day moxifloxacin
injection conversion to oral dosage form rule.
Results: The average age of patients using Moxifloxacin was 67.47  16.24.
According to the bacteria results, 11 people (10%) were Haemophilus influ-
enzae, 9 people in 110 (8.1%) were Staphylococcus aureus, and 8 people
(7.2%) were Klebsiella pneumonia. Sixty-six people (60 %) administered mox-
ifloxacin as the empirical therapy with bacterial culture growth nothing. A
total of 94 people (85.5%) were counted as reasonableness in Moxifloxacin
utilization. There are 49 people (44.5% ) converted from injection to an
oral dosage form of Moxifloxacin in 7 days and 14 people (12.7%) used less
than seven days then converted to an oral dosage form.
Conclusion: This research shows that Moxifloxacin rationality was counted
as 85.5% (94/110), and the conversion ratio for oral dosage forms was
counted as 44.5% (49/110) which is unsatisfactory. By this study, evalua-
tion of patients’ conversion ratio of the injection to oral provided a refer-
ence for the attending physicians. In order to enhance the patient’s
compliance, pharmacotherapy effective and reduce the enormous health
care costs, we expect the conversion rate will be improved and reach
100%.PS 1-002
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Purpose: Purpose of this study was to evaluate utilization appropriate for
the number of cases receving daptomycin in a regional hospital in Taichung,
Taiwan.
Methods: We performed a retrospective descriptive chart review to evaluate
the appropriate utilization of daptomycin. Cases were recruited from an
electronic report for all patients who had received daptomycin between
Jan 2013 and June 2014. Indication, diagnosis, bacterial culture, and doses
information were collected. The daptomycin dosage regimen was appro-
priate for patients according to their renal function. Total boday weight
was used to calculate doses and creatinin clearance (Clcr) calculated by
Cockcroft-Gault Equation. We also evaluated de-escalated therapy occurred
as an indicator of recovery.
Result: In this study, thirty-eight cases in 24 male and 13 female were
included. The average age was 65.49  12.91. Staphylococcus aureus
(MRSA) were isolated in 25 cases with 11 vancomycin MIC>1.5 ug/mL cases.
Enterococcus faecium (VRE) were isolated in 2 cases. Thirteen cases were
diagnosed as osteomylitis, eight cases were bacteremia with MRSA infection,
four were sepsis and septic shock, and three cases were catheter line infec-
tion with MRSA. The average dosage was 7.34  1.65 mg/kg (median 7.14
mg/kg) and average using days were 20  14.78 days (median 15 days). All
cases were performed renal function monitoring. There were 15 cases
with renal dysfunction but one case administering without any adjustment
by Clcr. After completion of daptomycin treatment, twenty-one cases
were de-escalated to oral antibiotics. Moreover, nine cases were considered
as inappropriate since growth nothing in bacteria culture in 5 cases and
other 4 cases with non-methcillin resistance Staphylococcus aureus, non-
vancomycin resistance Enterococcus faecalis, or Acinetobacter baumannii,
respectively.
Conclusion: Daptomycin usage guidance has been established in ensuring
appropriate prescription at the regional hospital. Computerized order
entering system can help infectious disease specialists to review the pre-
scription of daptomycin. It is anticipated that reserving daptomycin appro-
priate in 100%.PS 1-003
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Purpose: Surgical antibiotic practice (Surgical Antibiotic Prophylaxis) is one
of the components of antimicrobial stewardship program (AMS) and is
included in the WHO surgical patient safety checklist. Surgical antibiotic
prophylaxis is recommended to prevent, reduce occurrence surgical site in-
fections. Therefore it is important that policies and guidelines on SAP are
enforced.
Methods: The Infectious Disease Section (IDS) and Infection Prevention and
Control Office (IPCO) finalized guidelines on SAP after series of consultations
